Hypercholesterolemia, i.e., elevated low-density lipoprotein cholesterol (LDL-C) level in the blood is directly associated with a high risk of cardiovascular events. Several lipid-lowering therapies are available to attain the clinical goal of LDL-C levels in patients with or without cardiovascular diseases.

In this survey, we intend to gain insights about doctors’ general view on LDL management for lowering the cardiovascular risks in patients .